Haemodynamics, fluids & transfusion

Epidemiology of platelet transfusion in critically ill patients: a multicentre observational prospective study

J Crit CarePublished Secondary analysis of a prospective multicentre observational study

Authors' conclusion

In this large study, 42% of platelet transfusions were not aligned with guidelines. Prophylactic platelet transfusion was the indication with the lowest adherence to guidelines.

Study context

Population
Critically ill patients receiving platelet transfusions975 platelet transfusions
Participants
310 patients
Primary endpoint
Platelet transfusion indications, pre-transfusion platelet count and adherence to guidelines
Methodological detailspre-planned secondary analysis
  • Pre-planned secondary analysis

Primary result

As reported in the abstract

Platelet transfusions given in accordance with guidelines
Transfusions in accordance with guidelines
58% (95% CI 55-61)
Prophylactic transfusions in thrombocytopenic patients
41.7%
Prophylactic transfusions before invasive procedure
19.7%
Platelet concentrates to treat major bleeding
210 (21.5%)
Platelet concentrates to treat minor bleeding
166 (17.0%)
Median platelet count, prophylactic transfusion
14 × 109/L (IQR 8-23 × 109/L)
Median platelet count, prior to invasive procedure
21 × 109/L (IQR 12-36 × 109/L)
Median platelet count, prior to therapeutic transfusion
43 × 109/L (IQR 27-66 × 109/L)

Further findings

OutcomeProphylacticPre-procedure or bleedingAbsolute difference (percentage points) (95% CI)
Predicted probability of non-adherence to guidelines (exploratory multivariable analysis)Exploratory · model-based76.4%28.5%47.8 (40.7–55.0)

Original publication

Epidemiology of platelet transfusion in critically ill patients: a multicentre observational prospective study. J Crit Care. Published 30 September 2026. doi:10.1016/j.jcrc.2026.155765

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.